Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection - Wikidata - awgldk - TriplyDB

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

http://www.wikidata.org/entity/Q24538985

about

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection The Antibody Response against HIV-1 Virological features associated with the development of broadly neutralizing antibodies to HIV-1 Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications Phylogeny-aware gap placement prevents errors in sequence alignment and evolutionary analysis Accurately measuring recombination between closely related HIV-1 genomes Modeling HIV-1 drug resistance as episodic directional selection A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection Appreciating HIV type 1 diversity: subtype differences in Env.The utility of protein structure as a predictor of site-wise dN/dS varies widely among HIV-1 proteins.HIV-1 envelope subregion length variation during disease progression An evaluation of phylogenetic methods for reconstructing transmitted HIV variants using longitudinal clonal HIV sequence data.Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host.Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression.Frequent toggling between alternative amino acids is driven by selection in HIV-1 Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.The cat and mouse of HIV-1 antibody escape.Targeting Trojan Horse leukocytes for HIV prevention.Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants.Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1 Evolution of the human immunodeficiency virus type 2 envelope in the first years of infection is associated with the dynamics of the neutralizing antibody response.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressors CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.Evolutionary and structural features of the C2, V3 and C3 envelope regions underlying the differences in HIV-1 and HIV-2 biology and infection.Genetic variation and HIV-associated neurologic disease.Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection Association of HIV diversity and survival in HIV-infected Ugandan infants.Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein.

P2860

Q21245045-A35D49BB-FF9D-4472-8611-38C755544453 Q27000889-A9C5606F-31E8-492E-AC96-F321DFB68D62 Q27025177-EB1F58C2-4BAC-4F04-A52D-5F400AF13215 Q27468696-E81149D9-BF85-4D8C-BD68-8F233D18294B Q27489000-55AC052C-4D5E-4E00-94D8-B670393AF46D Q27654848-17168F74-3AA3-46A5-A248-2EA36D25430C Q27657377-F51BA487-E42F-4B91-A4E8-BE03F91147AB Q28284481-9052D890-B0C0-44C6-88AE-FCCFE69771A8 Q28473807-DF9FC33C-F5EA-4239-A572-7FF9C0070CC3 Q28483642-7725FD44-46F8-4FC7-A36B-DE7690E1D74B Q28743092-B854B2F5-20A6-439D-9F75-4A365C63D38B Q28751926-A05E1DBC-E7A7-4D3A-A884-073786020CF7 Q28752503-32523AE8-28AD-47B0-9CFE-E02942D15BE8 Q29619510-AF57A86A-775D-4285-8F9C-127BDBD7A47C Q30375834-4A6B37C6-E52A-407E-8A1F-FC9D53451CB6 Q30380281-2656F156-2A6F-4E63-B058-4BBA95717F46 Q30397933-2E82938A-7CAD-49E4-9A68-1F099DBD6183 Q30781299-316ED720-30B0-48D0-8FBE-197DDBF5F589 Q31034710-451AE4CE-4A46-41D6-8399-FD9D2AC81605 Q33269794-82AB5C8D-CE8E-4EF9-BF6F-532842373770 Q33274194-AB400B1E-203E-4AEC-A86A-D21FBBD199F9 Q33392723-0D15CED8-C1DD-4275-AA33-304CBC4044BA Q33394563-0EFC9790-D864-4019-83C7-D59BC5A6D84D Q33504599-801E61FF-1659-4B77-BA6D-DF0A3A9CB424 Q33504604-2418733D-0D4C-43F1-BC13-52255DEB5C5F Q33504607-FFBB74A5-4297-43F0-8DDF-2076DD784255 Q33518390-1C87F91B-9068-4CC3-8554-603EFF0872A3 Q33533351-D2F2BA54-656C-4AD1-A09B-80872EF6F91A Q33558279-202FD517-1021-4981-8E3A-A9BCD11BA3B1 Q33591409-7CDD7FAC-09DE-48C4-A0B2-86CF662CA053 Q33676640-301AFB7F-1806-49A1-918B-83FD594E8F4E Q33725673-35FF516F-C8F8-4CC5-BC94-0E44E49B61F0 Q33743734-998D44C2-4857-4350-810C-A625CC66A325 Q33749206-E3659C2F-4FB9-4946-9D30-844A911C9004 Q33807535-27E9C39E-DDA0-4D22-BA20-0B1AF316E9BD Q33809419-D6085CB8-C3ED-4FED-99FF-1FF0F97F0402 Q33819189-579BDFFB-62F6-4E12-B561-3E54F863785D Q33847798-0152E56D-2F7F-45B0-9224-CB0983CCF3FB Q33886570-BC5480EB-601B-439D-90F4-2CC5F29A5D44 Q33955745-BFB1BD9A-C431-4066-9CAD-563C5BAD619C

P2860

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection

http://www.wikidata.org/entity/Q24538985

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Neutralizing antibody response ...... pe during recent HIV infection

@ast

Neutralizing antibody response ...... pe during recent HIV infection

@en

Neutralizing antibody response ...... pe during recent HIV infection

@nl

type

label

Neutralizing antibody response ...... pe during recent HIV infection

@ast

Neutralizing antibody response ...... pe during recent HIV infection

@en

Neutralizing antibody response ...... pe during recent HIV infection

@nl

prefLabel

Neutralizing antibody response ...... pe during recent HIV infection

@ast

Neutralizing antibody response ...... pe during recent HIV infection

@en

Neutralizing antibody response ...... pe during recent HIV infection

@nl

P1433

Q24538985-C1138736-CB88-4070-9CCD-B5BA1C79EB01

P1476

Q24538985-3E4DDC96-F6B2-43CB-A14E-E34FB05A7D9E

P2093

Q24538985-1A4EE75C-ADE8-4820-A89A-4108FC338A36

Q24538985-336FBE27-79FB-42AE-95E0-3AACA73D4A40

Q24538985-88114F97-BD77-4575-A14A-B8AE35BADE36

Q24538985-9ADF0FCF-B7A6-4242-8D65-E352860D376F

Q24538985-A68B87CB-C672-4647-8AF5-FFBA937A4B83

Q24538985-AC18215E-090F-458A-8836-DB3768C88389

Q24538985-BFFF3EC2-9E84-46F5-91FD-1E9EC904635B

Q24538985-CF9F740C-A1F9-4F09-BCB0-3A16A7F620F7

Q24538985-D13AD797-1095-460B-8FF8-C2E58654611E

Q24538985-EFA495C6-04EE-4A51-AAAB-7A319BE89CD7

P2860

Q24538985-007531EF-E39B-469A-B990-AD7B0E36C022

Q24538985-05E89176-E481-49AA-99BE-C790A9CF631F

Q24538985-07F4D452-FFAC-4971-AE3A-A22A0F444B11

Q24538985-0E1B313A-77A6-4C0E-8619-0EC9C06FE0A7

Q24538985-13723A34-4A7C-419D-AF34-686AA5301B16

Q24538985-15A8D3B2-1E01-4FD7-A34E-F1055272C7E4

Q24538985-16594BA5-4723-4815-B419-D00B5C67A18E

Q24538985-1DE9E6F7-F29F-42E7-BDD1-660D9CED486C

Q24538985-25798614-83B4-4BB5-A415-7BE31E923250

Q24538985-2A026D3F-879B-4BEB-8A09-62AB89CB9BA0

P304

Q24538985-5FF34611-B7B9-42A6-BF0F-B3BB0AB3283A

P31

Q24538985-902C638B-9DDB-4AAA-8306-7785F7764246

P3181

Q24538985-D0DC9FED-5528-43B9-8773-AC6F00ED72E6

P356

Q24538985-D13B24E4-A397-4877-916A-601F3B675F83

P407

Q24538985-6129F634-9C5B-4664-9401-022C4A8CA317

P433

Q24538985-6C7DC27A-D101-4067-86DA-49B841D7FE71

P478

Q24538985-D21F8AEC-52F1-4335-B4AF-FA415F116170

P50

Q24538985-73DBF872-A75C-43BD-B771-A3E5C5820313

Q24538985-F61FED85-6E34-43BD-AB93-06F8CEC80D63

P577

Q24538985-4068D1C1-97AC-4F3B-A37D-01674A30D79E

P5875

Q24538985-91C47EBE-295E-4E51-BAC6-7333AD3708E6

P698

Q24538985-A5B67663-9224-42D4-8F1D-9148B2F32655

P921

Q24538985-3AED2CFE-CC13-48E3-97AE-E2017457D11B

Q24538985-C4785C8B-3FA1-4D89-9FAA-168990E9D6E4

P932

Q24538985-D76A3A03-9723-4562-ACA9-396D93116F53

P3181

P356

PNAS.0504658102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Neutralizing antibody response ...... pe during recent HIV infection

@en

P2093

Colombe Chappey

http://www.w3.org/2001/XMLSchema#string

Davey M Smith

http://www.w3.org/2001/XMLSchema#string

Douglas D Richman

http://www.w3.org/2001/XMLSchema#string

Ellen Paxinos

http://www.w3.org/2001/XMLSchema#string

Jeff Beauchaine

http://www.w3.org/2001/XMLSchema#string

Justin Galovich

http://www.w3.org/2001/XMLSchema#string

Simon D W Frost

http://www.w3.org/2001/XMLSchema#string

Susan J Little

http://www.w3.org/2001/XMLSchema#string

Terri Wrin

http://www.w3.org/2001/XMLSchema#string

Yang Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Codon-substitution models for heterogeneous selection pressure at amino acid sites

Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions

Identification of common molecular subsequences

Timing the ancestor of the HIV-1 pandemic strains

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

HyPhy: hypothesis testing using phylogenies

Antibody neutralization and escape by HIV-1

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Viral dynamics in human immunodeficiency virus type 1 infection

P304

18514-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3509231

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0504658102

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Christos J Petropoulos

Sergei L Kosakovsky Pond

P577

2005-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7429711

http://www.w3.org/2001/XMLSchema#string

P698

16339909

http://www.w3.org/2001/XMLSchema#string

P921

P932

1310509

http://www.w3.org/2001/XMLSchema#string